Stem Cell Companies
Andrew J. Waskey
NUMEROUS COMPANIES HAVE been organized that are seeking to develop advances in stem cell research and technology. New breakthroughs in stem cell research and new medical cures would result in large income revenues for patented stem cell lines and procedures. The vast majority of stem cell companies are publicly traded on the NASDAQ, the American Stock Exchange (AMEX), the Over—the-Counter market (OTC or OTCBB), on smaller regional exchanges, and on other stock exchanges around the world. It is estimated by stock analysts that there are over 200 companies engaged in developing stem cell products worldwide and that number is growing. Advanced Cell Technology, Inc. (OTCBB symbol ACTC.OB) is based in Los Angeles. It is using stem cell technology in the field of regenerative medicine to create patient—specific therapies in the treatment of heart disease. Astrom Biosciences (NASDAQ symbol ASTM) is a leader in the development of autologous cell products for ...